Effects of Alcohol History on Effects of Nitrous Oxide - 9
NCT00000257 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2015-05-28
Summary
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiates, and benzodiazepine antagonists will be made. To determine effects of alcohol history on the reinforcing, subjective and psychomotor effects of nitrous oxide in healthy volunteers.
Conditions
- Alcohol-Related Disorders
- Opioid-Related Disorders
- Substance-Related Disorders
Interventions
- DRUG
-
0% N2O and 10% N2O
- DRUG
-
0% N2O and 20% N2O
- DRUG
-
0% N2O and 30% N2O
- DRUG
-
0% N2O and 40% N2O
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Chicago
lead OTHER
Principal Investigators
-
James Zacny, Ph.D. · University of Chicago
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 37 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1995-09-30
- Primary Completion
- 1997-04-30
- Completion
- 1997-04-30
Countries
- United States
Study Locations
More Related Trials
-
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040 ·Status: RECRUITING ·Phase: PHASE1
-
Interactive Effects of IV Ethanol and IV Nicotine
NCT01814410 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Sex Differences in the Response to Abstinence From Alcohol.
NCT03827460 ·Status: RECRUITING ·Phase: PHASE1
-
Cannabidiol for Alcohol Use Disorder
NCT03904849 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal
NCT02823977 ·Status: WITHDRAWN ·Phase: PHASE4
-
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
NCT04523922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Oxytocin Treatment of Alcohol Dependence
NCT02251912 ·Status: COMPLETED ·Phase: PHASE2
-
Abuse and Addiction in ICU
NCT02951793 ·Status: UNKNOWN
-
Oxytocin Treatment of Alcohol Dependence
NCT02275611 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Treatment of Alcohol Withdrawal
NCT01212185 ·Status: COMPLETED ·Phase: PHASE1
-
Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
NCT00936377 ·Status: COMPLETED ·Phase: NA
-
Effects of Acetate and Alcohol on Brain Function
NCT02542150 ·Status: COMPLETED ·Phase: NA
-
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
NCT02299921 ·Status: RECRUITING
-
Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD
NCT04664790 ·Status: WITHDRAWN ·Phase: NA
-
Synergistic Effects of Anxiety and Alcohol Use Among Latinos and Its Sociocultural Mechanisms
NCT03807817 ·Status: COMPLETED ·Phase: NA
-
Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
NCT00027079 ·Status: COMPLETED ·Phase: PHASE2
-
Cannabidiol Effects on Blood Alcohol Level and Intoxication
NCT06105138 ·Status: COMPLETED ·Phase: NA
-
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
NCT06070649 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of Prescription Medications in Marijuana Users
NCT00893074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
NCT02058251 ·Status: COMPLETED ·Phase: PHASE1
-
Alcohol, Behavior, and Brain Imaging
NCT03930446 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Endotoxin on Alcohol Consumption
NCT04527185 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
NCT00612352 ·Status: COMPLETED ·Phase: NA
-
Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger
NCT02579317 ·Status: COMPLETED ·Phase: NA
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2